Generic Name and Formulations:
Diatrizoate meglumine 300mg/mL; soln for inj; contains organically bound iodine 141mg/mL.
Indications for CYSTOGRAFIN:
Take laxative night before exam; low residue diet day before. Individualize. Fill bladder with 25–300mL depending on age of patient and degree of bladder irritability; >300mL may be used if bladder capacity allows.
Severe sensitivity reactions may occur; have emergency equipment available. Bronchial asthma. Significant allergies. Active UTI. Pregnancy (Cat.C).
Radiopaque contrast agent.
May interfere with urine specimens.
Hypersensitivity reactions, hypothyroidism.
Bottles (100mL, 300mL)—1; Dilute (300mL)—10
Neurology Advisor Articles
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Congress Passes Bill to Fight Opioid Crisis
- Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
- Review of Factors Impacting Sport-Related Concussion Headaches
- Anodal tDCS Offers Possible Benefit for Improving Item Recall in Post-Stroke Aphasia
- Hospitalization Tied to Brain Abnormalities in Older Adults
- Spending Often Persists in High-Cost Medicare-Medicaid Eligible
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure